0591-3713

Generic: ezetimibe

Labeler: actavis pharma, inc.
NDC Directory DRUG FOR FURTHER PROCESSING DRUG FOR FURTHER PROCESSING Active

Drug Facts

Product Profile

Brand Name
Generic Name ezetimibe
Labeler actavis pharma, inc.
Dosage Form TABLET
Active Ingredients

ezetimibe 10 mg/1

Identifiers & Regulatory

Product NDC 0591-3713
Product ID 0591-3713_c175d215-1642-413d-b1e9-9cbad5e863f3
Product Type DRUG FOR FURTHER PROCESSING
Marketing Category DRUG FOR FURTHER PROCESSING
Marketing Start 2017-06-12
Marketing End 2027-02-28

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05913713
Hyphenated Format 0591-3713

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ezetimibe (source: label)
Generic Name ezetimibe (source: ndc)
Application Number ANDA200831 (source: label)
Routes
oral
source: label

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 100000 TABLET in 1 BOX (0591-3713-00)
source: ndc

Packages (1)

0591-3713-00 100000 TABLET in 1 BOX (0591-3713-00)

Ingredients (1)

ezetimibe (10 mg/1)

Linked Drug Pages (1)

Ezetimibe ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "c175d215-1642-413d-b1e9-9cbad5e863f3", "openfda": {}, "finished": false, "packaging": [{"description": "100000 TABLET in 1 BOX (0591-3713-00)", "package_ndc": "0591-3713-00", "marketing_end_date": "28-FEB-27", "marketing_start_date": "12-JUN-17"}], "product_id": "0591-3713_c175d215-1642-413d-b1e9-9cbad5e863f3", "dosage_form": "TABLET", "product_ndc": "0591-3713", "generic_name": "Ezetimibe", "labeler_name": "Actavis Pharma, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "EZETIMIBE", "strength": "10 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_end_date": "20270228", "marketing_start_date": "20170612"}